The global fluorescent immunoassay market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of infectious diseases and rising demand for rapid diagnostic tests. The infectious diseases segment accounted for the largest share in the global fluorescent immunoassay market in 2018, followed by endocrinology and oncology segments. North America was the leading region in terms of revenue contribution in 2018, followed by Europe and Asia Pacific.
- Fluorescent immunoassay is a type of immunoassay that uses fluorescent labels to detect the presence of an analyte in a sample.
- The use of fluorescence-based detection methods has increased in recent years due to their sensitivity, specificity, and ability to measure low concentrations of analytes.
- The market for fluorescence-based detection methods is expected to grow as more research is conducted on the benefits and applications for these types of assays.
- Fluorescent immunoassays are used in many different fields including clinical diagnostics, environmental monitoring, food safety testing, and forensics.
Industry Growth Insights published a new data on “Fluorescent Immunoassay Market”. The research report is titled “Fluorescent Immunoassay Market research by Types (ELISA, Rapid Test), By Applications (Infectious Diseases, Endocrinology, Oncology), By Players/Companies F.Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho-Clinical Diagnostics (U.S.), bioMerieux SA (France)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fluorescent Immunoassay Market Research Report
By Type
ELISA, Rapid Test
By Application
Infectious Diseases, Endocrinology, Oncology
By Companies
F.Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho-Clinical Diagnostics (U.S.), bioMerieux SA (France)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Fluorescent Immunoassay Market Report Segments:
The global Fluorescent Immunoassay market is segmented on the basis of:
Types
ELISA, Rapid Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infectious Diseases, Endocrinology, Oncology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F.Hoffmann-La Roche Ltd (Switzerland)
- Siemens AG (Germany)
- Abbott Laboratories (U.S.)
- Beckman Coulter (U.S.)
- Ortho-Clinical Diagnostics (U.S.)
- bioMerieux SA (France)
Highlights of The Fluorescent Immunoassay Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ELISA
- Rapid Test
- By Application:
- Infectious Diseases
- Endocrinology
- Oncology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fluorescent Immunoassay Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fluorescent immunoassay is a laboratory technique that uses fluorescent dyes to identify specific proteins in a sample. The dyes are attached to antibodies that specifically bind to the target protein. When the sample is analyzed, the antibodies will bind to any proteins that have been stained with the fluorescent dye, which will then allow for their identification and measurement.
Some of the key players operating in the fluorescent immunoassay market are F.Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho-Clinical Diagnostics (U.S.), bioMerieux SA (France).
The fluorescent immunoassay market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fluorescent Immunoassay Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fluorescent Immunoassay Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fluorescent Immunoassay Market - Supply Chain
4.5. Global Fluorescent Immunoassay Market Forecast
4.5.1. Fluorescent Immunoassay Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fluorescent Immunoassay Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fluorescent Immunoassay Market Absolute $ Opportunity
5. Global Fluorescent Immunoassay Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fluorescent Immunoassay Market Size and Volume Forecast by Type
5.3.1. ELISA
5.3.2. Rapid Test
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fluorescent Immunoassay Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fluorescent Immunoassay Market Size and Volume Forecast by Application
6.3.1. Infectious Diseases
6.3.2. Endocrinology
6.3.3. Oncology
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fluorescent Immunoassay Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fluorescent Immunoassay Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fluorescent Immunoassay Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fluorescent Immunoassay Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fluorescent Immunoassay Demand Share Forecast, 2019-2026
9. North America Fluorescent Immunoassay Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fluorescent Immunoassay Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fluorescent Immunoassay Market Size and Volume Forecast by Application
9.4.1. Infectious Diseases
9.4.2. Endocrinology
9.4.3. Oncology
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fluorescent Immunoassay Market Size and Volume Forecast by Type
9.7.1. ELISA
9.7.2. Rapid Test
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fluorescent Immunoassay Demand Share Forecast, 2019-2026
10. Latin America Fluorescent Immunoassay Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fluorescent Immunoassay Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fluorescent Immunoassay Market Size and Volume Forecast by Application
10.4.1. Infectious Diseases
10.4.2. Endocrinology
10.4.3. Oncology
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fluorescent Immunoassay Market Size and Volume Forecast by Type
10.7.1. ELISA
10.7.2. Rapid Test
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fluorescent Immunoassay Demand Share Forecast, 2019-2026
11. Europe Fluorescent Immunoassay Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fluorescent Immunoassay Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fluorescent Immunoassay Market Size and Volume Forecast by Application
11.4.1. Infectious Diseases
11.4.2. Endocrinology
11.4.3. Oncology
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fluorescent Immunoassay Market Size and Volume Forecast by Type
11.7.1. ELISA
11.7.2. Rapid Test
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fluorescent Immunoassay Demand Share, 2019-2026
12. Asia Pacific Fluorescent Immunoassay Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fluorescent Immunoassay Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fluorescent Immunoassay Market Size and Volume Forecast by Application
12.4.1. Infectious Diseases
12.4.2. Endocrinology
12.4.3. Oncology
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fluorescent Immunoassay Market Size and Volume Forecast by Type
12.7.1. ELISA
12.7.2. Rapid Test
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fluorescent Immunoassay Demand Share, 2019-2026
13. Middle East & Africa Fluorescent Immunoassay Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fluorescent Immunoassay Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fluorescent Immunoassay Market Size and Volume Forecast by Application
13.4.1. Infectious Diseases
13.4.2. Endocrinology
13.4.3. Oncology
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fluorescent Immunoassay Market Size and Volume Forecast by Type
13.7.1. ELISA
13.7.2. Rapid Test
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fluorescent Immunoassay Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fluorescent Immunoassay Market: Market Share Analysis
14.2. Fluorescent Immunoassay Distributors and Customers
14.3. Fluorescent Immunoassay Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. F.Hoffmann-La Roche Ltd (Switzerland)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens AG (Germany)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott Laboratories (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beckman Coulter (U.S.)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ortho-Clinical Diagnostics (U.S.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. bioMerieux SA (France)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
